Price $3.19 |
Market Cap
186.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.0
|
P/S
4.93
|
Dividend %
-
|
|
P/CF
20.4
|
P/FCF
4.0
|
Op. Cash Flow
47.8K
|
FCF
0.7
|
|
Op. Margin
-30.60%
|
Net Margin
-27.30%
|
ROE
-22.70%
|
ROI
-43.50%
|
|
ROA
-11.20%
|
EPS Growth
77.20%
|
Current Ratio
3.0
|
Debt/Equity
4.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $2.08 | - | - | 87.4M | Strong Buy |
| Cesca Therapeutics Inc (KOOL) | $2.95 | - | - | 6.1M | Strong Buy |
| CYANOTECH CORP (CYAN) | $3.03 | - | - | 18.3M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.28 | - | - | 10.6M | Strong Buy |
| Spectral Medical Inc (EDTXF) | $0.28 | - | - | 61.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
